122 related articles for article (PubMed ID: 7775259)
21. Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma.
Williams CL; Hayes VY; Hummel AM; Tarara JE; Halsey TJ
J Cell Biol; 1993 May; 121(3):643-54. PubMed ID: 8387530
[TBL] [Abstract][Full Text] [Related]
22. Measurement of tumor cell cohesion and suppression of invasion by E- or P-cadherin.
Foty RA; Steinberg MS
Cancer Res; 1997 Nov; 57(22):5033-6. PubMed ID: 9371498
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin).
Yoneda J; Saiki I; Fujii H; Abe F; Kojima Y; Azuma I
Clin Exp Metastasis; 1992 Jan; 10(1):49-59. PubMed ID: 1733647
[TBL] [Abstract][Full Text] [Related]
24. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion.
Feltes CM; Kudo A; Blaschuk O; Byers SW
Cancer Res; 2002 Nov; 62(22):6688-97. PubMed ID: 12438268
[TBL] [Abstract][Full Text] [Related]
25. E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells.
Tamm I; Cardinale I; Kikuchi T; Krueger JG
Proc Natl Acad Sci U S A; 1994 May; 91(10):4338-42. PubMed ID: 8183909
[TBL] [Abstract][Full Text] [Related]
26. Nerve growth factor mediates its pro-invasive effect in parallel with the release of a soluble E-cadherin fragment from breast cancer MCF-7/AZ cells.
Dollé L; Oliveira MJ; Bruyneel E; Hondermarck H; Bracke M
J Dairy Res; 2005; 72 Spec No():20-6. PubMed ID: 16180717
[TBL] [Abstract][Full Text] [Related]
27. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines.
Lapyckyj L; Castillo LF; Matos ML; Gabrielli NM; Lüthy IA; Vazquez-Levin MH
J Cell Physiol; 2010 Mar; 222(3):596-605. PubMed ID: 19957299
[TBL] [Abstract][Full Text] [Related]
28. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of bestatin on the growth of human leukemic cells.
Sakurada K; Imamura M; Kobayashi M; Tachibana N; Abe K; Tanaka M; Okabe M; Morioka M; Kasai M; Sugiura T
Acta Oncol; 1990; 29(6):799-802. PubMed ID: 2223152
[TBL] [Abstract][Full Text] [Related]
30. Sialylation of E-cadherin does not change the spontaneous or ET-18-OMe-mediated aggregation of MCF-7 human breast cancer cells.
Steelant WF; Recchi MA; Noë VT; Boilly-Marer Y; Bruyneel EA; Verbert A; Mareel MM; Delannoy P
Clin Exp Metastasis; 1999 May; 17(3):245-53. PubMed ID: 10432010
[TBL] [Abstract][Full Text] [Related]
31. Enhancing effect of ubenimex (bestatin) on proliferation and differentiation of hematopoietic progenitor cells, and the suppressive effect on proliferation of leukemic cell lines via peptidase regulation.
Shibuya K; Chiba S; Hino M; Kitamura T; Miyagawa K; Takaku F; Miyazano K
Biomed Pharmacother; 1991; 45(2-3):71-80. PubMed ID: 1912372
[TBL] [Abstract][Full Text] [Related]
32. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
[TBL] [Abstract][Full Text] [Related]
34. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.
Vizirianakis IS; Chen YQ; Kantak SS; Tsiftsoglou AS; Kramer RH
Int J Oncol; 2002 Jul; 21(1):135-44. PubMed ID: 12063560
[TBL] [Abstract][Full Text] [Related]
35. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
36. [Growth inhibitory effects of ubenimex on leukemic cell lines resistant to chemotherapeutic agents].
Fujii H; Yosizawa K; Maruyama S; Abe F
Jpn J Antibiot; 1996 Dec; 49(12):1109-15. PubMed ID: 9032597
[TBL] [Abstract][Full Text] [Related]
37. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells.
Shridhar R; Zhang J; Song J; Booth BA; Kevil CG; Sotiropoulou G; Sloane BF; Keppler D
Oncogene; 2004 Mar; 23(12):2206-15. PubMed ID: 14676833
[TBL] [Abstract][Full Text] [Related]
38. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms.
Chen H; Paradies NE; Fedor-Chaiken M; Brackenbury R
J Cell Sci; 1997 Feb; 110 ( Pt 3)():345-56. PubMed ID: 9057087
[TBL] [Abstract][Full Text] [Related]
39. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
40. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
Nam JS; Ino Y; Sakamoto M; Hirohashi S
Clin Cancer Res; 2002 Jul; 8(7):2430-6. PubMed ID: 12114449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
